New study tests innovative cancer treatment for dogs
Medicine is constantly making progress and now there is a promising new treatment method for cancer in dogs. CAR-T cell therapy could be a revolutionary way to help our beloved four-legged friends.
CAR-T cell therapy is an immunotherapy in which the body's immune system is stimulated to recognise and attack cancer cells. This method has already been successfully used in the treatment of cancer patients and has proven to be extremely effective.
Scientists have now decided to test CAR-T cell therapy in dogs. In a clinical trial, dogs with a certain type of lymphoma, which is common in dogs, are being treated. The idea is that the dog's modified immune cells should be able to recognise and destroy the cancer cells.
The study is being conducted by Dr Smith and his team, who are experts in the field of veterinary medicine. They are confident that CAR-T cell therapy can deliver similar positive results in dogs as it does in humans.
The treatment is carried out in several steps. Firstly, blood cells are taken from the dog, which are then genetically modified in the laboratory to produce CAR-T cells. These special cells are then returned to the dog to boost the immune system and help fight the cancer.
The study is still in its early stages, but the initial results are promising. Some of the treated dogs have already shown significant improvement and there is hope that CAR-T cell therapy could be an effective treatment option for cancer in dogs.
If the trial is successful, it could be a major breakthrough in veterinary medicine. Cancer in dogs is a serious disease that is often difficult to treat, and CAR-T cell therapy could offer new hope for affected dogs and their owners.
It remains to be seen how the study will develop and whether CAR-T cell therapy will actually become a recognised treatment option for dogs. However, the results so far are promising and give us hope that we could soon have an effective and gentle method of fighting cancer in our beloved four-legged friends.
Michael Verneris with his dog Sadie - one of the initiators of the study
Extract from the study - innovative cancer treatment for dogs:
Solid tumours in our sights
In humans, osteosarcoma is the most common bone tumour in adolescents and young adults. Paediatric and young adult patients who have metastatic osteosarcoma at the time of diagnosis or who suffer a relapse after initial treatment have a poor prognosis: the survival rate after five years is no more than 30 %.Verneris said that there has been very little progress in this area for years.
Dow said the new clinical trial is a first step.
„We will investigate bone cancer, other sarcomas and possibly brain tumours in studies with dogs diagnosed with cancer, paving the way for clinical trials in humans,“ he said.
Dogs are similar to humans in many ways, including the way their immune system recognises and reacts to malignant tumours.
„Dogs are vaccinated like humans, they have infections, and their tumours usually develop slowly,“ says Dow. „By the time their tumour develops, their immune system has become accustomed to the presence of the tumour, similar to humans with cancer. That's part of the reason why treating dogs can help advance CAR T-cell therapy for paediatric cancers.“.
The veterinarian pointed out that pet owners should understand that it is still too early in CAR T-cell research to predict success.
„We want people to understand the importance of collaborative research like this that explores new and better ways to treat cancer with innovative models,“ he said. „The research can benefit not only people, but pets as well.
https://news-cuanschutz-edu.cdn.ampproject.org/c/s/news.cuanschutz.edu/gates/car-t-cell-trial-for-canines-launched?hs_amp=true
Summary of innovative cancer treatment for dogs
An innovative cancer treatment for dogs is currently being researched: CAR-T cell therapy. This innovative cancer treatment for dogs uses the dog's own immune system to fight cancer cells, a method that has already achieved positive results in humans.
This innovative cancer treatment for dogs is now being trialled in a clinical study focusing on lymph node cancer in dogs. The researchers hope that the innovative cancer treatment will be as effective for dogs as it is for human patients.
Dr Smith's team, which is developing this innovative cancer treatment for dogs, already has experience in the field of veterinary medicine and is optimistic about the effectiveness of the therapy. The innovative cancer treatment for dogs takes place in several steps and begins with the removal and genetic modification of the dog's blood cells to produce the CAR-T cells.
This innovative cancer treatment for dogs is then continued by reinfusing the CAR-T cells into the dog to fight the cancer. Initial results of the study are promising and indicate that the innovative cancer treatment for dogs has the potential to revolutionise cancer therapy in dogs.
Innovative cancer treatment for dogs could be an effective future option for treating cancer, a disease that is often difficult to treat in dogs. This innovative cancer treatment for dogs is still in its infancy, but its successes could represent a significant advance in veterinary medicine. Oncology represent.
The innovative cancer treatment for dogs also aims to gain knowledge for the treatment of human osteosarcoma. In fact, the innovative cancer treatment for dogs is also being used to develop better treatment methods for children and young adults with poor prognoses.
The innovative cancer treatment for dogs can help to advance the understanding of cancer immunotherapies, as dogs and humans have similar immune systems. These parallels make it possible for findings from innovative cancer treatment for dogs to be transferred to humans.
It is important that pet owners interested in innovative cancer treatment for dogs understand that research is still in its infancy. However, there is great hope that innovative cancer treatment for dogs will not only be important for veterinary oncology, but also for human oncology.